The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations
Open accessAbstract
Motivation: Drug combination therapy has become an increasingly promising method in the treatment of cancer. However, the number of possible drug combinations is so huge that it is hard to screen synergistic drug combinations through wet-lab experiments. Therefore, computational screening has become an important way to prioritize drug combinations. Graph neural network has recently shown remarkable performance in the prediction of compound–protein interactions, but it has not been applied to the screening of drug combinations. Results: In this paper, we proposed a deep learning model based on graph neural network and attention mechanism to identify drug combinations that can effectively inhibit the viability of specific cancer cells. The feature embeddings of drug molecule structure and gene expression profiles were taken as input to multilayer feedforward neural network to identify the synergistic drug combinations. We compared DeepDDS (Deep Learning for Drug–Drug Synergy prediction) with classical machine learning methods and other deep learning-based methods on benchmark data set, and the leave-one-out experimental results showed that DeepDDS achieved better performance than competitive methods. Also, on an independent test set released by well-known pharmaceutical enterprise AstraZeneca, DeepDDS was superior to competitive methods by more than 16% predictive precision. Furthermore, we explored the interpretability of the graph attention network and found the correlation matrix of atomic features revealed important chemical substructures of drugs. We believed that DeepDDS is an effective tool that prioritized synergistic drug combinations for further wet-lab experiment validation. Availability and implementation: Source code and data are available at https://github.com/Sinwang404/DeepDDS/tree/master
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Semi-supervised classification with graph convolutional networks
Kipf, T. N., & Welling, M. (2016) · arXiv · doi:10.48550/arxiv.1609.02907 · Cited by 24,853
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D. G., et al. (2012) · Genome Research · doi:10.1101/gr.132159.111 · Cited by 5,061
Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
Gradient boosting machines, a tutorial
Natekin, A., & Knoll, A. (2013) · Frontiers in Neurorobotics · doi:10.3389/fnbot.2013.00021 · Cited by 3,887
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107
Impact of high-throughput screening in biomedical research
Macarron, R., Banks, M. N., Bojanic, D., Burns, D. J., Cirovic, D. A., Garyantes, T., Green, D. V. S., Hertzberg, R. P., Janzen, W. P., Paslay, J. W., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3368 · Cited by 1,364
Xiong, Z., Wang, D., Liu, X., Zhong, F., Wan, X., Li, X., Li, Z., Luo, X., Chen, K., Jiang, H., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00959 · Cited by 1,053
Self-citation(1953) · PubMed · Cited by 942
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Random Forest for Bioinformatics
Qi, Y. (2012) · Ensemble Machine Learning · doi:10.1007/978-1-4419-9326-7_11 · Cited by 754
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Di Veroli, G. Y., Fornari, C., Wang, D., Mollard, S., Bramhall, J. L., Richards, F. M., & Jodrell, D. I. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw230 · Cited by 736
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 653
Small molecules, big impact: 20 years of targeted therapy in oncology
Bedard, P. L., Hyman, D. M., Davids, M. S., & Siu, L. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30164-1 · Cited by 610
High-throughput screening: new technology for the 21st century
Hertzberg, R. P., & Pope, A. J. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00110-1 · Cited by 539
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
Goel, S., Wang, Q., Watt, A. C., Tolaney, S. M., Dillon, D. A., Li, W., Ramm, S., Palmer, A. C., Yuzugullu, H., Varadan, V., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.006 · Cited by 470
Self-citationAn unbiased oncology compound screen to identify novel combination strategies
O'Neil, J., Benita, Y., Feldman, I., Chenard, M., Roberts, B., Liu, Y., Li, J., Kral, A., Lejnine, S., Loboda, A., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0843 · Cited by 407
Menden, M. P., Wang, D., Mason, M. J., Szalai, B., Bulusu, K. C., Guan, Y., Yu, T., Kang, J., Jeon, M., Wolfinger, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09799-2 · Cited by 363
Wang, X., Tian, L., Li, Y., Wang, J., Yan, B., Yang, L., Li, Q., Zhao, R., Liu, M., Wang, P., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01871-4 · Cited by 283
Self-citationDrug-Drug Interaction Extraction via Convolutional Neural Networks
Liu, S., Tang, B., Chen, Q., & Wang, X. (2016) · Computational and Mathematical Methods in Medicine · doi:10.1155/2016/6918381 · Cited by 261
Drug repurposing screens and synergistic drug‐combinations for infectious diseases
Zheng, W., Sun, W., & Simeonov, A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13895 · Cited by 247
ChemoPy: freely available python package for computational biology and chemoinformatics
Cao, D.-S., Xu, Q.-S., Hu, Q.-N., & Liang, Y.-Z. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt105 · Cited by 239
Liu, H., Zhang, W., Zou, B., Wang, J., Deng, Y., & Deng, L. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1007 · Cited by 230
Self-citationMotivating actions to mitigate plastic pollution
Jia, L., Evans, S., & Linden, S. V. D. (2019) · Nature Communications · doi:10.1038/s41467-019-12666-9 · Cited by 208
Liu, Q., & Xie, L. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1008653 · Cited by 203
Large-scale exploration and analysis of drug combinations
Li, P., Huang, C., Fu, Y., Wang, J., Wu, Z., Ru, J., Zheng, C., Guo, Z., Chen, X., Zhou, W., et al. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv080 · Cited by 195
Self-citationMatchMaker: A Deep Learning Framework for Drug Synergy Prediction
Kuru, H. I., Tastan, O., & Cicek, A. E. (2022) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3086702 · Cited by 186
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models
Zhang, T., Zhang, L., Payne, P. R. O., & Li, F. (2021) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0849-4_12 · Cited by 167
PharmKG: a dedicated knowledge graph benchmark for bomedical data mining
Zheng, S., Rao, J., Song, Y., Zhang, J., Xiao, X., Fang, E. F., Yang, Y., & Niu, Z. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa344 · Cited by 165
Thafar, M. A., Olayan, R. S., Ashoor, H., Albaradei, S., Bajic, V. B., Gao, X., Gojobori, T., & Essack, M. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00447-2 · Cited by 143
Systems Pharmacology of Adverse Event Mitigation by Drug Combinations
Zhao, S., Nishimura, T., Chen, Y., Azeloglu, E. U., Gottesman, O., Giannarelli, C., Zafar, M. U., Bénard, L., Badimón, J. J., Hajjar, R. J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006548 · Cited by 135
Modjtahedi, H., Cho, B. C., Michel, M. C., & Solca, F. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0967-3 · Cited by 117
Anticancer drug synergy prediction in understudied tissues using transfer learning
Kim, Y., Zheng, S., Tang, J. P., Zheng, W. J., Li, Z., & Jiang, X. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa212 · Cited by 101
Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells
Liu, T., Yacoub, R., Taliaferro-Smith, L. D., Sun, S., Graham, T. R., Dolan, R. S., Lobo, C., Tighiouart, M., Yang, L. P. H., Adams, A. L., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0925 · Cited by 100
Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
Giles, T. D., Weber, M. A., Basile, J., Gradman, A. H., Bharucha, D. B., Chen, W., & Pattathil, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60614-0 · Cited by 90
A classification model for lncRNA and mRNA based on k-mers and a convolutional neural network
Wen, J., Liu, Y., Shi, Y. H., Huang, H., Deng, B., & Xiao, X. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3039-3 · Cited by 86
DTF: Deep Tensor Factorization for predicting anticancer drug synergy
Sun, Z., Huang, S., Jiang, P., & Hu, P. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa287 · Cited by 85
Ferreira, D., Adega, F., & Chaves, R. (2013) · InTech eBooks · doi:10.5772/53110 · Cited by 80
Pathway-Guided Deep Neural Network toward Interpretable and Predictive Modeling of Drug Sensitivity
Deng, L., Cai, Y., Zhang, W., Yang, W., Gao, B., & Liu, H. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00331 · Cited by 71
Self-citationYe, L., Mayerle, J. V., Ziesch, A., Reiter, F. P., Gerbes, A. L., & Toni, E. N. D. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0165-7 · Cited by 66
Liu, H., Zhang, W., Nie, L., Ding, X., Luo, J., & Zou, L. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3288-1 · Cited by 64
Self-citationGeppert, H., Horváth, T., Gärtner, T., Wrobel, S., & Bajorath, J. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700461s · Cited by 63
The whole transcriptome and proteome changes in the early stage of myocardial infarction
Li, Y., Wang, C., Li, T., Ma, L., Fan, F., Jin, Y., & Shen, J. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0152-z · Cited by 58
Wen-ji, Z., Li, Y., Wei, M.-N., Chen, Y., Qiu, J.-G., Jiang, Q., Yang, Y., Zheng, D.-W., Qin, W.-M., Huang, J.-R., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.011 · Cited by 40
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer
Vitiello, P. P., Martini, G., Mele, L. L., Giunta, E. F., Falco, V. D., Ciardiello, D., Belli, V., Cardone, C., Matrone, N., Poliero, L., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01811-8 · Cited by 39
AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors
Oliveira, R. J. D. S., Melendez, M. E., Martinho, O., Zanon, M. F., Viana, L. D. S., Carvalho, A. L., & Reis, R. M. (2017) · Oncotarget · doi:10.18632/oncotarget.18395 · Cited by 38
Systematic Quality Control Analysis of LINCS Data
Cheng, L., & Li, L. (2016) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12107 · Cited by 35
Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells
Hung, M., Chen, I., Lung, J.-H., Lin, P.-Y., Li, Y., & Tsai, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158395 · Cited by 34
COVID19 inhibitors: A prospective therapeutics
Akhtar, M. J. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104027 · Cited by 34
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening
Kragh, K. N., Gijón-Cordero, D., Maruri-Aransolo, A., Antonelli, A., Coppi, M., Kolpen, M., Crone, S. G., Tellapragada, C., Hasan, B., Radmer, S., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa543 · Cited by 32
Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow
Potekhina, E. S., Bass, D. Y., Kelmanson, I. V., Fetisova, E. S., Ivanenko, A. V., Belousov, V. V., & Bilan, D. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010148 · Cited by 31
Modeling drug combination effects via latent tensor reconstruction
Wang, T., Szedmák, S., Wang, H., Aittokallio, T. A., Pahikkala, T., Cichońska, A., & Rousu, J. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab308 · Cited by 28
Sorafenib sensitizes melanoma cells to vemurafenib through ferroptosis
Tang, F., Li, S., Liu, D., Chen, J., & Han, C. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.01.62 · Cited by 27
A High-Throughput Yeast Assay Identifies Synergistic Drug Combinations
Torres, N. P., Lee, A. Y., Giaever, G. N., Nislow, C., & Brown, G. W. (2013) · Assay and Drug Development Technologies · doi:10.1089/adt.2012.503 · Cited by 24
Pereira, T. C., de Menezes, R. T., de Oliveira, H. C., de Oliveira, L. D., & Scorzoni, L. (2021) · Pathogens and Disease · doi:10.1093/femspd/ftab001 · Cited by 18
Trends in Phase II Trials for Cancer Therapies
Azam, F., & Vázquez, A. (2021) · Cancers · doi:10.3390/cancers13020178 · Cited by 17
Verderosa, A. D., Dhouib, R., Hong, Y., Anderson, T. K., Heras, B., & Totsika, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-81007-y · Cited by 15
Comparative analysis of molecular representations in prediction of drug combination effectsPreprint
Zagidullin, B., Wang, Z., Guan, Y., Pitkänen, E., & Tang, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.16.439299 · Cited by 1
Chen, T., Wang, Z., Li, L., Li, D., Li, Z., Chang, X., Bian, P., Liang, G., Wang, Q., & Xie, T. (2025) · Schloss Dagstuhl – Leibniz-Zentrum für Informatik · doi:10.4230/lipics.ecoop.2025.6
Cited by
Attention is all you need: utilizing attention in AI-enabled drug discovery
Zhang, Y., Liu, C., Liu, M., Liu, T., Lin, H., Huang, C.-B., & Ning, L. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad467 · Cited by 377
Wang, S., Yang, C., & Chen, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146799 · Cited by 65
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
Hu, J., Gao, J., Fang, X., Liu, Z., Wang, F., Huang, W., Wu, H., & Zhao, G. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac302 · Cited by 65
xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-Seq Data
Gong, J., Hao, M., Zeng, X., Liu, C., Ma, J., Cheng, X., Wang, T., Zhang, X., & Song, L. (2023) · doi:10.1101/2023.03.24.534055 · Cited by 17
Zheng, Q., & Ding, Q. (2022) · PLOS ONE · doi:10.1371/journal.pone.0268007 · Cited by 16
Metadata
- Authors
- Wang, J., Liu, X., Shen, S., Deng, L., & Liu, H.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-25
- Volume
- 23
- Issue
- 1
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W3203908308
- Cited by
- 261
- References
- 63
- FWCI
- 15.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.